Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 84 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8211857

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Soricimed Biopharma Inc. · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  2. US 8211876

    Compositions for treatment of inflammatory diseases

    The Regents of the University of Oklahoma · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  3. US 8193152

    Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds

    The Board of Regents of the University of Texas System · Granted Jun 5, 2012 · Expires May 31, 2032

    granted

  4. US 8192720

    Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseases

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Jun 5, 2012 · Expires May 31, 2032

    granted

  5. US 8188072

    Benzodiazepinone compounds useful in the treatment of skin conditions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 29, 2012 · Expires May 24, 2032

    granted

  6. US 8187817

    Diagnosis, treatment, and prevention of vascular disorders using IL-1 autoantibodies

    XBIOTECH INC. · Granted May 29, 2012 · Expires May 24, 2032

    granted

  7. US 8183207

    Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules

    Five Prime Therapeutics, Inc. · Granted May 22, 2012 · Expires May 17, 2032

    granted

  8. US 8183274

    Treatment of hyperproliferative disorders with diarylhydantoin compounds

    The Regents of the University of California · Granted May 22, 2012 · Expires May 17, 2032

    granted

  9. US 8178109

    Compositions and methods of use for MGD-CSF in disease treatment

    Five Prime Therapeutics, Inc. · Granted May 15, 2012 · Expires May 10, 2032

    granted

  10. US 8173120

    Method of preventing reduced feed intake in animals and treatment of disease conditions

    Precision Nutrition Pty Ltd · Granted May 8, 2012 · Expires May 3, 2032

    granted

  11. US 8163281

    Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted

  12. US 8158627

    Compositions and treatments using pyridazine compounds and cholinesterase inhibitors

    Northwestern University · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  13. US 8158675

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  14. US 8158677

    Treatment of viral infections by modulation of host cell metabolic pathways

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Apr 17, 2012 · Expires Apr 12, 2032

    granted

  15. US 8153604

    CNS-tumor treatment method and composition

    The Regents of the University of California · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  16. US 8147833

    Prevention and treatment of synucleinopathic and amyloidogenic disease

    The Regents of the University of California · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted

  17. US 8143226

    Tyrosine kinase receptor antagonists and methods of treatment for breast cancer

    The Regents of the University of California · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted

  18. US 8143218

    Treatment of skin, and wound repair, with thymosin beta 4

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted

  19. US 8138351

    Treatment of duchenne muscular dystrophy

    Summit Corporation Plc · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted

  20. US 8129349

    Treatment of disease by inducing cell apoptosis

    The Regents of the University of California · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted

  21. US 8124653

    Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia

    The Board of Regents of the University of Texas System · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  22. US 8119590

    Prevention and treatment of restenosis by local administration of drug

    Esperion Therapeutics, Inc. · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted

  23. US 8119649

    Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia

    The Board of Regents of the University of Texas System · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted

  24. US 8119827

    Compounds for treatment of cell proliferative diseases

    The Board of Regents of the University of Texas System · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.